Benzonatate is in the drug class antitussives. Benzonatate is used to treat Cough. Mucinex Fast-Max Severe Congestion Cold. A total of 570 drugs are known to interact with Mucinex Fast-Max Severe Congestion Cold. Mucinex fast-max severe congestion cold is in the drug class upper respiratory combinations.
Benzonatate is in the drug class antitussives. Benzonatate is used to treat Cough. Mucinex Fast-Max Severe Congestion Cold. A total of 570 drugs are known to interact with Mucinex Fast-Max Severe Congestion Cold. Mucinex fast-max severe congestion cold is in the drug class upper respiratory combinations.
Benzonatate is in the drug class antitussives. Benzonatate is used to treat Cough. Mucinex Fast-Max Severe Congestion Cold. A total of 570 drugs are known to interact with Mucinex Fast-Max Severe Congestion Cold. Mucinex fast-max severe congestion cold is in the drug class upper respiratory combinations.
benzonatate. A total of 1 drugs are known to interact with benzonatate. Benzonatate is in the drug class antitussives. Benzonatate is used to treat Cough. Mucinex Fast-Max Severe Congestion Cold. A total of 570 drugs are known to interact with Mucinex Fast-Max Severe Congestion Cold.
Mucinex Fast-Max DM Max. A total of 343 drugs are known to interact with Mucinex Fast-Max DM Max. Mucinex fast-max dm max is in the drug class upper respiratory combinations. Mucinex fast-max dm max is used to treat the following conditions: Cough; Expectoration; Drug and food interactions
. COMMON BRAND NAME(S): MooreBrand Severe Cold Relief, Mucinex Fast-Max, Mucinex Fast-Max Cold Flu, Mucinex Fast-Max Severe Congestion Cold, Mucinex
benzonatate. benzoyl perox-clindamycin-niacinamide-spironolact MUCINEX FAST-MAX DM MAX. MUCINEX FAST-MAX KICKSTART. MUCINEX FAST-MAX
BENZONATATE CAPSULE (AG) (ORAL). BENZONATATE 100 MG CAPSULE MUCINEX FAST-MAX DAY-NITE COLD-FLU CAPSULE OTC (ORAL). MUCINEX SINUS
No interactions were found between benzonatate and Mucinex Fast-Max Severe Congestion Cold. Dextromethorphan and guaifenesin. Mucinex DM 30 mg
Comments